Search International and National Patent Collections

1. (WO2017157326) NERVE GROWTH FACTOR MUTANT

Pub. No.:    WO/2017/157326    International Application No.:    PCT/CN2017/077038
Publication Date: Fri Sep 22 01:59:59 CEST 2017 International Filing Date: Sat Mar 18 00:59:59 CET 2017
IPC: C07K 14/48
A61K 38/18
A61P 25/00
Applicants: STAIDSON(BEIJING) BIOPHARMACEUTICALS CO.,LTD.
舒泰神(北京)生物制药股份有限公司
Inventors: WANG, Chao
王超
MA, Lei
马磊
DU, Tianfei
杜天飞
Title: NERVE GROWTH FACTOR MUTANT
Abstract:
Provided is a nerve growth factor mutant, wherein same is an amino acid sequence as shown by any one of SEQ ID No: 3 to SEQ ID No: 21 in the sequence listing. The advantage of the nerve growth factor mutant lies in that the mutation of a nerve growth factor can alleviate pain and side effects, falling within the field of biological pharmacy.